Maxcyte (MXCT) Change in Cash (2020 - 2026)

Maxcyte (MXCT) has 7 years of Change in Cash data on file, last reported at -$5.5 million in Q1 2026.

• Quarterly Change in Cash fell 22.43% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.8 million (down 877.11% YoY) and the FY2025 annual result came in at -$7.8 million, up 58.01% from the prior year.
• Change in Cash fell to -$5.5 million in Q1 2026 per MXCT's latest filing, from $7.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $192.0 million in Q1 2022 and bottomed at -$130.6 million in Q2 2022.
• The 5-year median for Change in Cash is -$4.5 million (2025), against an average of -$2.0 million.
• Peak annual rise in Change in Cash reached 220.27% in 2022, while the deepest fall reached 406.95% in 2022.
• Tracing MXCT's Change in Cash over 5 years: stood at -$32.0 million in 2022, then surged by 91.66% to -$2.7 million in 2023, then sank by 240.49% to -$9.1 million in 2024, then surged by 178.16% to $7.1 million in 2025, then sank by 177.66% to -$5.5 million in 2026.
• Per Business Quant, the three latest MXCT Change in Cash figures stand at -$5.5 million (Q1 2026), $7.1 million (Q4 2025), and -$2.3 million (Q3 2025).

Peer Comparison